Opioid Abuse Groups Criticize US FDA For Using Purdue Pharma-Connected Data Firm

 
• By Derrick Gingery

The advocates say the Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS) and its Substance Abuse Treatment Center Programs Combined Survey has conflicts of interest, as well as a connection to the infamous maker of OxyContin.

OxyContin on a shelf
Advocacy groups fighting the opioid crisis argue SAMHSA or other unconflicted organizations could provide the FDA the necessary opioid abuse data. • Source: Shutterstock

More from Drug Safety

More from Pink Sheet